BRIEF published on 10/28/2025 at 17:55, 7 months 28 days ago FUTRUE ajuste la rémunération en espèces pour le retrait forcé de PharmaSGP Assemblée Générale Squeeze-out Compensation En Espèces PharmaSGP Futrue GmbH
BRIEF published on 10/28/2025 at 17:55, 7 months 28 days ago FUTRUE Adjusts Cash Compensation for PharmaSGP Squeeze-Out General Meeting Squeeze-out Cash Compensation PharmaSGP Futrue GmbH
PRESS RELEASE published on 10/28/2025 at 17:50, 7 months 28 days ago FUTRUE increases adequate cash compensation under the squeeze-out FUTRUE increases adequate cash compensation under squeeze-out for PharmaSGP Holding SE minority shareholders. Cash compensation raised to EUR 30.64 per share effective immediately Squeeze-out Minority Shareholders Cash Compensation PharmaSGP Holding SE FUTRUE
BRIEF published on 09/22/2025 at 15:20, 9 months 3 days ago PharmaSGP Calls Extraordinary General Meeting for Squeeze-out Decision General Meeting Squeeze-out Share Transfer PharmaSGP Futrue GmbH
BRIEF published on 09/22/2025 at 15:20, 9 months 3 days ago PharmaSGP convoque une assemblée générale extraordinaire pour prendre une décision de retrait obligatoire Assemblée Générale Transfert D'actions PharmaSGP Retrait Forcé Futrue GmbH
PRESS RELEASE published on 09/22/2025 at 15:15, 9 months 3 days ago PharmaSGP convenes extraordinary general meeting to resolve on Squeeze-out PharmaSGP Holding SE convenes an extraordinary general meeting to resolve on squeeze-out of remaining shareholders. Cash compensation specified at EUR 29.33 per share Extraordinary General Meeting Squeeze-out Cash Compensation PharmaSGP Holding SE Futrue GmbH
BRIEF published on 09/11/2025 at 09:05, 9 months 14 days ago PharmaSGP Releases Preliminary Half-Year Figures for 2025 Adjusted EBITDA Germany PharmaSGP OTC Pharmaceuticals 2025 Revenues
BRIEF published on 09/11/2025 at 09:05, 9 months 14 days ago PharmaSGP publie ses chiffres préliminaires du premier semestre 2025 Allemagne EBITDA Ajusté PharmaSGP Chiffre D'affaires 2025 Médicaments En Vente Libre
PRESS RELEASE published on 09/11/2025 at 09:00, 9 months 14 days ago PharmaSGP publishes preliminary half-year figures for 2025 PharmaSGP Holding SE releases preliminary half-year figures for 2025, showing a 13.0% revenue increase. Adjusted EBITDA declined slightly due to higher expenses. Forecast aims for continued growth amidst global uncertainties Adjusted EBITDA Revenue Increase Growth Forecast PharmaSGP Half-Year Figures
BRIEF published on 08/06/2025 at 16:21, 10 months 19 days ago PharmaSGP annonce sa radiation de la Bourse de Francfort Bourse Bourse De Francfort Radiation PharmaSGP Futrue GmbH
Published on 06/25/2026 at 15:30, 5 hours 2 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/25/2026 at 15:00, 5 hours 32 minutes ago Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
Published on 06/25/2026 at 14:30, 6 hours 2 minutes ago Unusual Machines Expands Orlando Manufacturing Footprint to Support Battery Operations
Published on 06/25/2026 at 14:01, 6 hours 31 minutes ago Worksport (NASDAQ:WKSP) Regains $1 Bid Price Requirement, Announces CEO Town Hall, Highlights Multiple Recent Growth Drivers in CEO Letter
Published on 06/25/2026 at 14:00, 6 hours 32 minutes ago Horizon Aircraft's Leadership Team to Participate at Farnborough International Airshow 2026
Published on 06/25/2026 at 19:00, 1 hour 31 minutes ago EQS-Adhoc: H&R GmbH & Co. KGaA resolves to prepare for the transition from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange
Published on 06/25/2026 at 18:59, 1 hour 32 minutes ago OHB Digital Connect completes upgrade of military ground stations
Published on 06/25/2026 at 18:40, 1 hour 51 minutes ago Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts international conference on complex cardiac arrhythmias
Published on 06/25/2026 at 18:30, 2 hours 2 minutes ago Delisting of Northern Data AG Shares - Munich Stock Exchange Decides on the Timeline
Published on 06/25/2026 at 18:00, 2 hours 32 minutes ago EUROPLASMA: Projet de cession des activités de défense : poursuite des discussions
Published on 06/25/2026 at 18:45, 1 hour 46 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 2 hours 2 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 2 hours 42 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 06/25/2026 at 15:58, 4 hours 33 minutes ago 260625 BENETEAU Transactions sur actions propres
